Funding Ground-Breaking Cancer Research

Blog Comments Off

The Flint, Michigan, lead-in-the-water crisis has uncovered a massive health threat that extends across America. The issue is lead, and other environmental toxins, and what those toxins are doing to our health, including triggering the onset of cancer, particularly in our children.

Scientists have long believed that high concentrations of heavy metals are a major underlying cause of blood cancers. But at present, there is no definitive scientific research that demonstrates how lead, and other heavy metals, are connected to leukemia and other blood cancers.

Cancer Recovery Foundation has taken the major step of funding a scientific study at the world-renowned M.D. Anderson Cancer Center in Houston, Texas, to find the answer to this important question. The study represents an important and overlooked step toward developing less-toxic, more-effective and less-costly treatments for blood-based cancers.

The initial research will be focused on pediatric cancer patients — half of whom are newly diagnosed with acute lymphoblastic leukemia and half who are newly diagnosed with acute myeloid leukemia.


This ground-breaking research is headed by Maro Ohanian, D.O., Assistant Professor at the University of Texas M.D. Anderson Cancer Center. Dr. Ohanian is widely recognized as a pioneer in understanding the link between environmental toxins and leukemia.

This type of research seldom wins support in the competitive and largely pharmaceutical-based federal agency grant making environment. Metal accumulation and the need to eliminate toxic metals in the cancer treatment process represents a significant gap in current cancer treatment options. Moreover, answering the question of how accumulation of metals from food and water contribute to an individual’s risk for cancer may well lead to actual cancer prevention.

Cancer Recovery Foundation believes that an understanding of the impact of metal concentrations in leukemia patients could quickly lead to new therapeutic approaches. This would include incorporation of metal-targeted metal-binding agents during the course of leukemia treatment. It is hoped this research will lead to new and more effective treatments for leukemia, as well as other cancers, thus saving thousands of lives annually.

 



Photo Dynamic Therapy (PDT)

Blog Comments Off

Photo Dynamic Therapy incorporates light-activated chemicals to impair tumor growth.  Studies have shown that PDT can work as well as surgery or radiation therapy in treating certain kinds of cancers and pre-cancers. It has some advantages, such as:

  • It has no long-term side effects when used properly.
  • It’s less invasive than surgery.
  • It usually takes only a short time and is most often done as an outpatient.
  • It can be targeted very precisely.
  • Unlike radiation, PDT can be repeated many times at the same site if needed.
  • There’s little or no scarring after the site heals.
  • It often costs less than other cancer treatments.

But PDT has limits, too. It can only treat areas where light can reach. This means it’s mainly used to treat problems on or just under the skin, or in the lining of organs that can be reached with the light source. While some of the drugs can travel throughout the body, the treatment only works where the light shines. This is why PDT can’t be used to treat cancers that have spread to many places. Also, the drugs that are currently used leave people very sensitive to light for some time, so special precautions must be taken after the drugs are put in or on the body.

In short, patients should mention PDT to their doctor and determine if they are a candidate.



Re-stating our Position on Vitamin B17

Ask Greg FAQ's, Blog Comments Off

Greg,

I have (stage) IV breast cancer and I am doing well on Prejeta, Herceptin and Tomoxifin.  My last scan was NED. I was reading your book and following your nutrition and exercises as well as mind, body and spirit.

Your book I’m referring to is “Cancer: 50 Essential Things to Do.”  I really like your book and it has helped me greatly through my healing journey.

I did read that there was a vitamin curing stage four cancers called B17. I was wondering what your thoughts were about taking this vitamin, if it was safe and if you thought it would be a good idea to take while I am on Perjeta, Herceptin and tamoxifen?

Any advice would be greatly appreciated.

Michelle

BlogcontentSpacerGA

Dear Michelle,

I am not a fan of vitamin B17, also known as Laetrile and/or Amygdalin.  In over 20 years of following the claims made for this “cure,” I have never been able to talk to even one patient who can verify this is the reason for their recovery and survival.

The Cochrane Collaboration http://www.cochrane.org/ says:  The claims that laetrile or amygdalin have beneficial effects for cancer patients are not currently supported by sound clinical data. There is a considerable risk of serious adverse effects from cyanide poisoning after laetrile or amygdalin, especially after oral ingestion. The risk–benefit balance of laetrile or amygdalin as a treatment for cancer is therefore unambiguously negative.

You can find others who think differently.  Just Google “Vitamin B 17.  But my advice is, “No.”

Be well,

Greg Anderson



World Health Organization Classifies Air Pollution as THE Major Cause of Cancer

Blog Comments Off

AirPolutionThe air many of us breathe poses serious health risks, the World Health Organization says. On Thursday, it added cancer to the list.

Air pollution is a now officially a carcinogen, and there are no caveats about the new classification.

“We know that it is causing cancer in humans,” said spokesman Kurt Straif.

In 2010, lung cancer resulting from air pollution took the lives of 223,000 people worldwide. As pollution levels climb, so will the rate of cancer, the WHO said.

And there is only one way to stop it: Clean up the air…

See the full article here: http://www.cnn.com/2013/10/17/health/geneva-air-pollution-carcinogenic-who/

Get involved in a great organization
Children’s Cancer Recovery Foundation has established a Virtual Toy Drive to help generate funds for children battling cancer.  Learn more by visiting their website: www.childrenscancerrecovery.org



Does Orange Juice Have a Role in Cancer Recovery?

Blog Comments Off

woman eating orangeIn a forthcoming review article from Nutrition and Cancer: An International Journal, a publication of Routledge, researchers review available evidence that links orange juice with cancer chemoprevention. The review article, “Orange Juice and Cancer Chemoprevention” discusses the putative mechanisms involved in the process, the potential toxicity of orange juice, and the available data in terms of evidence-based medicine.

Orange juice has many potential positive effects when it comes to cancer, particularly because it is high in antioxidants from flavonoids such as hesperitin and naringinin. Evidence from previous in vitro studies has indicated that orange juice can reduce the risk of leukemia in children, as well as aid in chemoprevention against mammary, hepatic, and colon cancers. Biological effects of orange juice in vitro are largely influenced by the juice’s composition, which is dependent on physiological conditions of the oranges such as climate, soil, fruit maturation, and storage methods post-harvest.

The researchers acknowledge potential toxicity from orange juice if consumed in excess amounts—especially for children, hypertensive, kidney-compromised, and diabetics. Excessive drinking of orange juice for individuals from these groups has the potential to create noxious effects, hyperkalemia, and has been associated with both food allergies and bacterial outbreaks in cases where the juice was unpasteurized. “Excessive intake of any food, even for the healthiest, can lead to oxidative status imbalance,” wrote the researchers.

Further research is highly recommended to determine the biological connection between orange juice and cancer chemoprevention. Issues such as the type of cultivar and the amount consumed will also need clarification.

Overall, the review article summarizes several biological effects of orange juice that can contribute to chemoprevention, including antioxidant, antimutagenic and antigenotoxic, cytoprotective, hormonal, and cell signaling modulating effects. Orange juice has antimicrobial and antiviral action and modulates the absorption of xenobiotics. “OJ could contribute to chemoprevention at every stage of cancer initiation and progression,” the researchers explained. “Among the most relevant biological effects of OJ is the juice’s antigenotoxic and antimutagenic potential, which was shown in cells in culture and in rodents and humans.”

My recommendation:  One (1) glass a day.  Drink OJ that is fortified with vitamin D.

Greg



Follow Us on FacebookFollow Us on TwitterFollow Us on RSS